Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Current Assets: 2012-2024

Historic Current Assets for Veracyte (VCYT) over the last 13 years, with Dec 2024 value amounting to $372.3 million.

  • Veracyte's Current Assets rose 25.88% to $449.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $449.2 million, marking a year-over-year increase of 25.88%. This contributed to the annual value of $372.3 million for FY2024, which is 30.34% up from last year.
  • Latest data reveals that Veracyte reported Current Assets of $372.3 million as of FY2024, which was up 30.34% from $285.6 million recorded in FY2023.
  • Veracyte's 5-year Current Assets high stood at $375.7 million for FY2020, and its period low was $243.1 million during FY2021.
  • Over the past 3 years, Veracyte's median Current Assets value was $285.6 million (recorded in 2023), while the average stood at $302.2 million.
  • In the last 5 years, Veracyte's Current Assets spiked by 100.16% in 2020 and then crashed by 35.29% in 2021.
  • Over the past 5 years, Veracyte's Current Assets (Yearly) stood at $375.7 million in 2020, then slumped by 35.29% to $243.1 million in 2021, then increased by 2.28% to $248.6 million in 2022, then rose by 14.88% to $285.6 million in 2023, then soared by 30.34% to $372.3 million in 2024.